Octreotide Long-acting Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Octreotide Long-acting Injection, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors [Phase 2, Phase 3]